NVCR 8-K 2026-11-09

NovoCure Ltd (NVCR) 8-K dated 2026-11-09 — accession 0001645113-26-000085.

NovoCure Ltd (NVCR) is a medical devices company listed on US.

NovoCure Ltd filed a 8-K on 2026-11-09. Accession 0001645113-26-000085.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported NVCR revenue for 2025-12-31 was $655.4M. Net income was -$136.2M. Revenue was up 410.3% from 2022-12-31 to 2025-12-31. NVCR currently screens at market cap $1.99B.

Not investment advice. The NVCR SEC hub lists recent forms. The stock page is the research view.